The forecast data for Cardiac Glycosides use in Germany from 2024 to 2028 shows a decreasing trend. The values per thousand persons per day (defined daily dosage) are as follows:
- 2024: 1.8
- 2025: 1.5
- 2026: 1.2
- 2027: 1.0
- 2028: 0.8
Year-on-year variation in percentages:
- 2024 to 2025: -16.67%
- 2025 to 2026: -20.00%
- 2026 to 2027: -16.67%
- 2027 to 2028: -20.00%
Compound Annual Growth Rate (CAGR) from 2024 to 2028: -17.36%
The downward trend in the use of cardiac glycosides is significant and may be attributed to advancements in alternative therapies, increased focus on preventative cardiovascular care, and improved management practices. Close monitoring of these factors and their impact on the market will be crucial in future forecasts.
